Price target upside
AbCellera Biologics Inc. - Common Shares Price Target Upside or Downside
ABCL price target upside based on the current price and analyst average.
Direct answer
AbCellera Biologics Inc. - Common Shares's analyst target implies +60.8%.
The average target is $10.50 compared with a recorded current price of $6.53.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 7, 2026.
Verified data
- Current price
- $6.53
- Average price target
- $10.50
- High price target
- $13.00
- Low price target
- $7.00
- Target upside
- +60.8%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- August 7, 2026
- Valid through
- August 14, 2026